Upload
vuhanh
View
214
Download
1
Embed Size (px)
Citation preview
Physical Activity & Cancer – What We Know, What We Don’t Know
Anne McTiernan, MD, PhD Fred Hutchinson Cancer Research Center
Seattle, WA
What We Know
• Extensive epidemiologic research on relationship between global levels of aerobic physical activity & risk for common cancers
• Limited information on relationship between physical activity & cancer prognosis
• Emerging literature on exercise effects on cancer-related biomarkers in randomized clinical trials
Intensity of Physical Activity and Breast Cancer
Vigorous intensity activity Walking/cycling
Moderate intensity activity
Lynch et al., Rec Res Cancer Res 2011;186:13-42
Pooled Analysis of Leisure Time Physical Activity and Risks of 26 Types of Cancer
• NCI Cohort Consortium of 12 prospective cohorts • 1.44 million men and women aged 19-98 years • Comparison of 90th vs. 10th percentiles of
physical activity using random effects meta-analysis
• 13 cancer sites showed decreased risks with high vs. low levels of physical activity
• 2 cancer sites showed increased risk
Moore et al., JAMA Intern Med 2016
Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults (90th vs. 10th Percentile)
Moore S. et al. JAMA Int Med 2016; 176(6):816-25
Association of Physical Activity With Risk of Cancer May Be Attenuated by High BMI
Moore S. et al. JAMA Int Med 2016; 176(6):816-25
Church T. et al. PLoS One. 2011; 6(5): e19657.
Trends over 5 Decades in U.S. Occupation-Related Physical Activity (U.S. Bureau of Labor Statistics)
Meta-analysis: Sedentary Behavior (per 2 hours) & Cancer Risk
Schmid D, Leitzmann MF. JNCI 2014;106:dju098
Time Use & Physical Activity: a Shift Away from Movement Across the U.S. – Multinational Time Use Study
Ng et al. Obesity Reviews 2012;13(8): 659-680
Physical Activity & Breast Cancer Survival
Ballard-Barbash R, et al. J Natl Cancer Inst 2012;104(11):815-40
Physical Activity & Other Cancer Survival.
Ballard-Barbash et al. J Natl Cancer Inst 2012;104:815-840
Multi-center Randomized Controlled Trials of Exercise Effects on Survival
• Intense Exercise for Survival Among Men with Metastatic Castrate-Resistant Prostate Cancer (GAP4) – 12-mo, supervised high intensity aerobic & resistance
training vs. control – N=866 – Primary outcome: survival – Sponsor: Movember
• CHALLENGE Trial – High-risk stage II or stage III colon cancer, adjuvant
chemotherapy in past 2–6 months – 3-year structured aerobic exercise program – N=962 – Primary outcome: disease-free survival – Sponsor: NCI Canada Clinical Trials Group
Short-term Exercise Effects: Randomized Trials • Aerobic exercise:
– Reduces fatigue – Improves fitness, mood, overall quality of life – Reduces weight (moderately), increases lean
mass
• Resistance (strength) training: – Decreases lymphedema episodes & symptoms – Increases strength
• Combined aerobic + resistance: – Decreases arthralgia in aromatase inhibitor users
Galvao et al. JCO 2005; Schmitz K et al. N Engl J Med 2009; Courneya et al. JNCI 2013; Irwin ML et al. JCO 2015; Brown JC et al. CEBP 2010; Brown JC et al. PlosOne 2012; Ferrer RA et al. Ann Beh Med 2011
Impact of Exercise on Cancer-related Fatigue.
Justin C. Brown et al. Cancer Epidemiol Biomarkers Prev 2011
Total Physical Activity Before and After Diagnosis in Breast Cancer Survivors by Treatment (HEAL)
1515.5
1616.5
1717.5
1818.5
1919.5
20
Surgery Surgery +Radiation
Surgery +Chemo
Treatment
Hou
rs/w
eek
Before DiagnosisAfter Diagnosis
P<.05
P<.05
Irwin M. et al. Cancer 2003;97:1746-57
Potential Mechanisms for Exercise Effect
on Cancer Risk
↓ exercise
↑cancer
↑ inflammation
altered androgens
↑ insulin ↑ glucose
altered adipokines (↓adiponectin; ↑ leptin)
↑ oxidative stress??
↑ angiogenesis
↑ estrogens
↑adiposity
1-Year Aerobic Exercise Effects (225-360 m/wk) • Reduced:
– Weight, fat mass (mean 3-5 pounds) – Insulin (women) – Colon crypt cell proliferation (men)
• Reduced with fat loss: – Estrogens (women) – Androgens (women) – Angiogenesis markers PAI-1 (women) – C-reactive protein
• Reduced with ↑ VO2 max: – Prolactin (women) – F2 isoprostanes (women)
• No effect: – IGF-1, IGFBP-3, immune function, DNA damage repair,
estrogen metabolites, telomere length, global DNA methylation (LINE-1)
Physical Activity Effect on Estrogens in Women: Meta-Analysis of RCTs
Ennour-Idrissi et al. Breast Cancer Res 2015 Nov 5;17(1):139
Effects of Dietary Weight Loss & Exercise Interventions on Breast Cancer Biomarkers
in Postmenopausal Women
Purpose: To examine the individual and combined effects of 12-month dietary weight loss and exercise interventions on:
- estrone, estradiol, free estradiol - testosterone, free testosterone - sex hormone binding globulin - insulin resistance markers - inflammation
Methods: 12-months RCT, N=438, BMI >25, ages 50-75 yrs, healthy, no hormones, no smoking, inactive
Randomized
(N=438)
Control (N= 87)
Dietary weight loss
(N=118)
Aerobic Exercise
(N=117)
Diet + Exercise
(N=116)
Completed (N=80)
Completed (N=106)
Completed (N=108)
Completed (N=105)
Dietary Weight Loss Intervention
• Diabetes Prevention Program/Look Ahead* diet • Goal 10% weight loss by 6 months • Calorie deficit plus < 30% calories from fat
• 120-174: 1200 kcal • 175-219: 1500 kcal • 220-249: 1800 kcal • ≥ 250: 2000 kcal
• 2-4 individual sessions + group sessions – Weekly X 6 months, then monthly X 6 months with interim contacts
• Facility weighings • Home weighings at least weekly • Daily food logs • Participants attended a mean 91% of sessions
*Knowler et al. NEJM 2002; ;346:393-403; Wadden et al. Obesity 2006; 14:737-52
Exercise Intervention
• 45 minutes/day, 5 days/week – 3 days/week facility (FHCRC Prevention Center) – 2 days/week home
• Moderate-intensity aerobic activity (walking, elliptical, biking, other sports) – 60-75% VO2max
• 8 weeks progression to full program – Start at 15 minutes; 40% VO2max
• 80% of target 225 minutes/week achieved
% Weight Change normalized to baseline, 9% missing assumed no change
-15
-10
-5
Baseline 12 Months
% W
eigh
t Los
s (f
rom
bas
elin
e)
Diet Diet+Ex Ex Control
0
Foster-Schubert et al. Obesity 2012 Aug;20(8):1628-38
% Estrone Change
-20
-15
-10
-5
0
5
10
% Change Baseline to 12 Months
ControlDiet AloneExercise AloneDiet + Exercise * * +
*P<0.001 vs. CO
+ P<0.01 vs. CO Campbell K et al. J Clin Oncol. 2012 Jul 1;30(19):2314-26
% Estradiol Change
-30
-25
-20
-15
-10
-5
0
5
% Change Baseline to 12 Months
ControlDiet AloneExercise AloneDiet + Exercise * *
*P<0.001 vs. CO
Campbell K et al. J Clin Oncol. 2012 Jul 1;30(19):2314-26
% Testosterone Change
-10
-8
-6
-4
-2
0
2
% Change Baseline to 12 Months
ControlDiet AloneExercise AloneDiet + Exercise
*
*P=0.02 vs. CO
Campbell K et al. J Clin Oncol. 2012 Jul 1;30(19):2314-26
% Estrone Change by Weight Change
-20
-15
-10
-5
0
5
10
Diet Only Exercise Only Diet + Exercise
ControlGain/lost < 5%Lost >=5%
* * +
*Ptrend<0.001 vs. CO
+ Ptrend<0.01 vs. CO
Campbell K et al. J Clin Oncol. 2012 Jul 1;30(19):2314-26
% Estradiol Change by Weight Change
-30
-25
-20
-15
-10
-5
0
5
10
Diet Only Exercise Only Diet + Exercise
ControlGain/lost < 5%Lost >=5%
* * +
*Ptrend<0.0001 vs. CO
+ Ptrend<0.01 vs. CO
Campbell K et al. J Clin Oncol. 2012 Jul 1;30(19):2314-26
% Insulin Change
-35
-30
-25
-20
-15
-10
-5
0
% Change Baseline to 12 Months
ControlDiet AloneExercise AloneDiet + Exercise * *
*P<0.001 vs. CO
Mason et al. Am J Prev Med. 2011 Oct;41(4):366-75.
% Adiponectin Change * *
*P<0.001 vs. CO
Abbenhardt et al. J of Internal Medicine 2013 Aug;274(2):163-75.
% Change in C-Reactive Protein
-50
-40
-30
-20
-10
0
10
Control Diet Diet+Exercise Exercise
%
- 37.7% P= <.001 -46.9%
P= <.001
-11.4% P= .09
1.1%
Imayama et al. Cancer Research 2012; 72(9); 2314–26
-30
-20
-10
0
10
Control Diet Diet+Exercise Exercise
% Change in Interleukin-6
%
-24.3% P< .001
-21.9% P< .001
-2.0% P= .48
0.7%
Imayama et al. Cancer Research 2012; 72(9); 2314–26
% Fluorescent Oxidation Products Change
* *
*P<0.0001 vs. CO
Duggan C et al. Ca Prev Res 2016 (in press)
% F-2 Isoprostane Change * *
*P<0.0002 vs. CO
+P=0.01 vs. CO Duggan C et al. Ca Prev Res 2016 (in press)
+
What We Don’t Know about Physical Activity & Cancer
• Type, dose, timing of physical activity • Effects on risk for rare cancers • Effects on cancer subtypes • Needs in highly sedentary persons • Effects on cancer and cancer-related biomarkers in
diverse race/ethnic groups • Effects on biomarkers in target tissue • Long-term effects on cancer biomarkers • Acute effects on cancer biomarkers • Intermediary roles of muscle, fat, other tissue